Hyperprolactinemia is a condition characterized by elevated levels of prolactin, a hormone produced by the pituitary gland that plays a crucial role in reproductive health and lactation. This condition can result from various factors, including pituitary tumors (prolactinomas), certain medications, and systemic diseases. Symptoms may include irregular menstrual cycles, infertility, galactorrhea (unexpected milk production), and decreased libido. Advances in hyperprolactinemia medicine have led to effective treatment options, primarily through the use of dopamine agonists such as cabergoline and bromocriptine, which can lower prolactin levels and reduce tumor size. Additionally, ongoing research is exploring new therapeutic approaches and enhancing understanding of the condition’s underlying mechanisms. These advancements are improving management strategies and patient outcomes for those affected by hyperprolactinemia.
|
|
|
|
